½ÃÀ庸°í¼­
»óǰÄÚµå
1766289

¼¼°èÀÇ µ¿¹°¿ë Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)

Veterinary Orthopedic Implants Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ µ¿¹°¿ë Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀåÀº 2024³â 6¾ï 2,290¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, CAGR 8.3%·Î ¼ºÀåÇØ 2034³â±îÁö 14¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ÀÌ ¼ºÀåÀº Á¤Çü¿Ü°ú Ä¡·á³ª °ñ À±°û Çü¼º µîÀÇ °íµµÀÇ ¼öÀÇÇÐÀû ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ °è¼Ó ÃËÁøÇÏ´Â ¼¼°è ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ ¼ö Áõ°¡¿¡ µû¸¥ ¿µÇâÀÌ Å®´Ï´Ù.

µ¿¹°¿ë Á¤Çü¿Ü°ú ÀÓÇöõÆ® Market-IMG1

¶ÇÇÑ µ¿¹°ÀÇ Ãֽмö¼ú ÀÓÇöõÆ®ÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ¾÷°è Âü°¡Àڵ鿡°Ô »õ·Î¿î ±âȸ°¡ ź»ýÇß½À´Ï´Ù. ¶ÇÇÑ ÇöÀç ÁøÇà ÁßÀÎ R&D ³ë·ÂÀº ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ÀÓÇöõÆ® ±â¼ú °³¹ß¿¡ ÁßÁ¡À» µÎ°í ÀÖÀ¸¸ç, ¼±Áø±¹ ½ÃÀå°ú ½ÅÈï±¹ ½ÃÀå ¸ðµÎ¿¡¼­ ä¿ë·üÀÌ Å©°Ô ³ô¾ÆÁú °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¹üÀ§
½ÃÀÛ ¿¬µµ 2024³â
¿¹Ãø ¿¬µµ 2025-2034³â
½ÃÀÛ ±Ý¾× 6¾ï 2,290¸¸ ´Þ·¯
¿¹Ãø ±Ý¾× 14¾ï ´Þ·¯
CAGR 8.3%

¼öÀÇÇÐ ¼ºÇü ¿Ü°ú ¼ö¼úÀº µ¿¹Ý µ¿¹°ÀÇ ±Ù°ñ°Ý°è ÁúȯÀ» Ä¡·áÇϱâ À§ÇØ Æ¯È÷ ¼ö¿ä°¡ ³ô½À´Ï´Ù. ¶Ç, ü³»¿¡¼­ ÀÚ¿¬ÀûÀ¸·Î ¿ëÇØÇØ, Àç¼ö¼úÀÇ Çʿ伺À» ¾ø¾Ö´Â »ýü Èí¼ö¼º ÀÓÇöõÆ® Àç·á ¼ö¿äµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Æú¸®±Û¸®ÄÝ»ê°ú °°Àº Æú¸®¸Ó¸¦ »ç¿ëÇÏ¿© °³¹ßµÇ´Â °æ¿ì°¡ ¸¹Àº À̵é Àç·á´Â ¾ÈÀü¼º, È¿À²¼º, ºñ¿ë¸é¿¡¼­ ¶Ù¾î³ª±â ¶§¹®¿¡ Àα⸦ ¸ðÀ¸°í ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î º¼ ¶§, ½ÃÀåÀº ÀÓÇöõÆ®¿Í ±â±¸·Î ºÐ·ùµË´Ï´Ù. ÀÓÇöõÆ® ÀÌ ºÐ¾ß´Â 2024³â ½ÃÀåÀ» ¸®µåÇØ 4,200¸¸ ´Þ·¯ÀÇ Æò°¡ ±Ý¾×¿¡ À̸£·¶À¸¸ç, 2034³â¿¡´Â 9¾ï 7,790¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µ¿¹°À¯Çüº°·Î º¸¸é ½ÃÀåÀº ¼Òµ¿¹°, Áßµ¿¹°, ´ëµ¿¹°·Î ºÐ·ùµË´Ï´Ù. ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °ßÀÎÇÑ °ÍÀº ¼¼°è ¹Ý·Áµ¿¹° ¼ö Áõ°¡¿Í °ñÀý°ú °üÀýÀå¾Ö µî Á¤Çü¿Ü°úÀû ¹®Á¦ÀÇ ºóµµ Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ ¿Ü°ú Ä¡·á¿¡ ´ëÇÑ ¾×¼¼½º°¡ Çâ»óµÇ¾î ¹Ý·Áµ¿¹°ÀÇ ÁÖÀÎÀÌ Áú ³ôÀº Ä¡·á¿¡ ÅõÀÚÇÒ ÀÇ¿åÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ÀÌ ºÐ¾ßÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¿ëµµº°·Î ºÐ¼®ÇÏ¸é ½ÃÀå¿¡´Â °æ°ñ°í¿ø ¼öÆòÈ­°ñÀý¼ú(TPLO), °æ°ñ°áÀýÀüÀü¼ú(TTA), °üÀýġȯ¼ú, ¿Ü»ó, ±âŸ ¿ëµµ µîÀÇ ¼ö¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ Áß TPLO ¼ö¼úÀº ¿©ÀüÈ÷ ÁÖ¿ä ¿ëµµÀ̸ç 8.1%·Î 3¾ï 320¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµº°·Î º¸¸é, ½ÃÀåÀº µ¿¹° º´¿ø ¹× Áø·á¼Ò¿Í ±âŸ µ¿¹° ÀÇ·á½Ã¼³·Î ±¸ºÐµË´Ï´Ù. ¼³ºñ°¡ °®Ãß¾îÁø Áø·á¼Ò³ª º´¿øÀÌ °ßÁ¶ÇÏ°Ô Á¸ÀçÇØ, Á¾ÇÕÀûÀÎ ¼öÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀÌ, ÀÌ ºÐ¾ß¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì°¡ 2024³â ¼¼°è ½ÃÀåÀ» ¼±µµÇØ 41.9%ÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ÀÌ Áö¿ªÀº ¶ÇÇÑ ¿©·¯ ´ëÇü ¹°Ç° ÀÓÇöõÆ® Á¦Á¶¾÷üÀÇ Á¸Àç, ±ÔÁ¦ÀÇ ÇÕ¸®È­, Ãæ½ÇÇÑ ÀÓ»ó ¿¬±¸ Ȱµ¿ µîÀÇ ÇýÅÃÀ» ¹Þ°í ÀÖÀ¸¸ç, ÀÌµé ¸ðµÎ°¡ÀÌ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº Àû´çÈ÷ ÅëÇյǾî ÀÖÀ¸¸ç, ÁÖ¿ä ±â¾÷Àº °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ Àμö, Á¦ÈÞ, Á¦Ç° Çõ½Å, R&D ÅõÀÚ µîÀÇ Àü·«À» ä¿ëÇϰí ÀÖ½À´Ï´Ù. »óÀ§ 5°³ ±â¾÷(DePuy Synthes (Johnson & Johnson), Movora (Vimian Group), Veterinary Instrumentation, Arthrex Vet Systems, Rita Leibinger GmbH)´Â ¼¼°è ½ÃÀå ¼öÀÍÀÇ ¾à 60%¸¦ Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ±â¾÷µéÀº µ¿¹°¿ë Á¤Çü¿Ü°ú ÀÇ·á¿¡ ´ëÇÑ ¼¼°èÀûÀÎ ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ Æ÷Æ®Æú¸®¿À È®Ãæ°ú ½Å½ÃÀå ÁøÀÔ¿¡ °è¼Ó ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
    • °ø±ÞÀÚÀÇ »óȲ
    • °¢ ´Ü°è¿¡¼­ÀÇ ºÎ°¡°¡Ä¡
    • ¹ë·ùüÀο¡ ¿µÇâÀ» ÁÖ´Â ¿äÀÎ
  • ¾÷°è¿¡ ¹ÌÄ¡´Â ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °³ Á¤Çü¿Ü°ú ÁúȯÀÇ ¹ß»ý·ü Áõ°¡
      • ¼öÀÇ Á¤Çü¿Ü°ú ±â¼úÀÇ Áøº¸
      • ¹Ý·Áµ¿¹° º¸Çè Àû¿ë ¹üÀ§ È®´ë
      • Á¤Çü¿Ü°úÀû ¹®Á¦¿¡ °üÇÑ ¹Ý·Áµ¿¹° ÁÖÀÎÀÇ ÀǽÄÀÇ °íÁ¶
    • ¾÷°èÀÇ ÀáÀçÀû À§Çè ¹× °úÁ¦
      • Á¤Çü¿Ü°ú ¼ö¼ú°ú ÀÓÇöõÆ®ÀÇ °í¾×ÀÇ ºñ¿ë
      • ¼÷·ÃµÈ ¼öÀÇ»ç Á¤Çü¿Ü°úÀÇ ºÎÁ·
    • ½ÃÀå ±âȸ
      • ÀÓÇöõÆ® Á¦Á¶¾÷ü¿Í µ¿¹° º´¿øÀÇ Çù·Â°ú ÆÄÆ®³Ê½Ê °­È­
      • ½ÅÈï ½ÃÀåÀÇ ±Þ¼ÓÇÑ µµ½ÃÈ­¿Í ¼Òµæ Áõ°¡
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±â¼úÀÇ »óȲ
  • ¹Ì·¡ ½ÃÀå µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼Ò°³
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • ÁÖ¿ä ¹ßÀü
    • ÇÕº´Àμö
    • ÆÄÆ®³Ê½Ê ¹× Çù¾÷
    • ½ÅÁ¦Ç° ¹ß¸Å
    • È®Àå °èȹ

Á¦5Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Á¦Ç°º°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ÀÓÇöõÆ®
    • Ç÷¹ÀÌÆ®
      • TPLO Ç÷¹ÀÌÆ®
      • TTA Ç÷¹ÀÌÆ®
      • ¿Ü»ó Ç÷¹ÀÌÆ®
      • ƯÁ¦ Ç÷¹ÀÌÆ®
      • ±âŸ Ç÷¹ÀÌÆ®
    • °üÀý ÀÓÇöõÆ®
    • »À³ª»ç ¹× ¾ÞÄ¿
    • Çɰú ¿ÍÀ̾î
    • ±âŸ ÀÓÇöõÆ®
  • ±â±â

Á¦6Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : µ¿¹° À¯Çüº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ¼ÒÇü ¹× ÁßÇü µ¿¹°
    • °³
    • °í¾çÀÌ
    • ±âŸ ¼ÒÇü ¹× ÁßÇü µ¿¹°
  • ´ëÇü µ¿¹°

Á¦7Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ¿ëµµº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • °æ°ñ °í¿ø ¼öÆò °ñÀý¼ú(TPLO)
  • °æ°ñ °áÀý ÀüÁø¼ú(TTA)
  • °üÀý ġȯ¼ú
    • °í°üÀý ġȯ¼ú
    • ¹«¸­ °üÀý ġȯ¼ú
    • ÆÈ²ÞÄ¡ °üÀý ġȯ¼ú
    • ¹ß¸ñ ġȯ¼ú
  • ¿Ü»ó
  • ±âŸ ¿ëµµ

Á¦8Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • µ¿¹° º´¿ø ¹× Áø·á¼Ò
  • ±âŸ ÃÖÁ¾ ¿ëµµ

Á¦9Àå ½ÃÀå Ãß°è ¹× ¿¹Ãø : Áö¿ªº°, 2021-2034³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • AmerisourceBergen Corporation(Cencora, Inc.)
  • Arthrex Vet Systems
  • B. Braun
  • BlueSAO
  • DePuy Synthes(Johnson & Johnson)
  • Fusion Implants
  • GerVetUSA
  • GPC Medical Ltd.
  • Integra LifeSciences
  • Movora(Vimian Group)
  • Narang Medical Limited
  • Ortho Max
  • Orthomed
  • Rita Leibinger
  • Veterinary Instrumentation
JHS 25.07.17

The Global Veterinary Orthopedic Implants Market was valued at USD 622.9 million in 2024 and is estimated to grow at a CAGR of 8.3% to reach USD 1.4 billion by 2034. This growth is largely influenced by the rising number of pet owners worldwide, which continues to drive demand for advanced veterinary services such as orthopedic procedures and bone contouring. Technological advancements in veterinary surgery-especially minimally invasive techniques like arthroscopy-are also helping to accelerate recovery time, increasing acceptance among pet parents.

Veterinary Orthopedic Implants Market - IMG1

Furthermore, greater awareness about the benefits of modern surgical implants in animals has created new opportunities for industry participants. Investments in animal healthcare infrastructure in emerging economies have further reinforced market expansion. Additionally, ongoing R&D efforts are focused on developing cost-effective and user-friendly implant technologies, which are expected to significantly boost adoption rates across both developed and developing markets.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$622.9 Million
Forecast Value$1.4 Billion
CAGR8.3%

Veterinary orthopedic procedures are in particularly high demand for treating musculoskeletal conditions in companion animals. The prevalence of injuries and degenerative diseases in animals, especially those involving joints and ligaments, continues to rise, prompting increased use of surgical implants. Demand is also climbing for bioabsorbable implant materials that dissolve naturally in the body, eliminating the need for follow-up removal surgeries. These materials, often developed using polymers like polylactic acid and polyglycolic acid, are gaining popularity for their safety, efficiency, and cost advantages. Innovations such as smart implants embedded with sensors or drug-releasing coatings are also becoming more prominent. These devices help monitor healing processes and reduce post-operative infections, further enhancing treatment outcomes.

In terms of product type, the market is segmented into implants and instruments. The implants category is further broken down into plates, joint implants, bone screws and anchors, pins and wires, and other related components. This segment led the market in 2024, reaching a valuation of USD 442 million, and is expected to grow to USD 977.9 million by 2034. This dominance can be attributed to growing awareness around orthopedic care in pets and the increasing availability of sophisticated implant technologies.

By animal type, the market is categorized into small and medium animals and large animals. The small and medium animals segment-which includes dogs, cats, and other similarly sized animals-accounted for 72.6% of the market share in 2024 and is projected to expand at a CAGR of 8.5% through 2034. Growth in this segment is driven by the rising global pet population and the increasing frequency of orthopedic issues, such as fractures and joint disorders. Additionally, enhanced accessibility to surgical treatments and a greater willingness among pet owners to invest in high-quality care are further propelling segment growth.

When analyzed by application, the market includes procedures such as Tibial Plateau Leveling Osteotomy (TPLO), Tibial Tuberosity Advancement (TTA), joint replacement, trauma, and other uses. Among these, TPLO surgery remains a primary application, accounting for USD 141.2 million in 2024, and is projected to grow to USD 303.2 million by 2034, with a CAGR of 8.1%. This procedure is particularly known for restoring joint stability and promoting faster recovery in animals suffering from ligament injuries.

On the basis of end use, the market is segmented into veterinary hospitals and clinics and other veterinary care facilities. In 2024, veterinary hospitals and clinics dominated with a market value of USD 537.1 million, expected to reach USD 1.2 billion by 2034 at a CAGR of 8.5%. The robust presence of well-equipped clinics and hospitals, paired with the growing demand for comprehensive veterinary care, has been instrumental in driving this segment forward. Clinics and hospitals also serve as the initial point of consultation for most pet owners, making them key contributors to overall market revenue.

Geographically, North America led the global market in 2024, holding a share of 41.9%. High levels of pet ownership, rising disposable incomes, and strong demand for advanced veterinary care are core factors fueling regional growth. The region also benefits from the presence of several major veterinary implant manufacturers, streamlined regulatory pathways, and substantial clinical research activities, all of which contribute to the continued expansion of this market.

The market is moderately consolidated, with key players adopting strategies such as acquisitions, partnerships, product innovation, and R&D investments to maintain their competitive edge. The top five companies- DePuy Synthes (Johnson & Johnson), Movora (Vimian Group), Veterinary Instrumentation, Arthrex Vet Systems, and Rita Leibinger GmbH-collectively accounted for approximately 60% of global market revenue. These firms continue to focus on expanding their portfolios and entering new markets to address the growing global need for veterinary orthopedic care.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product
    • 2.2.3 Animal type
    • 2.2.4 Application
    • 2.2.5 End use
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Value addition at each stage
    • 3.1.3 Factor affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing incidence of orthopedic conditions in dogs
      • 3.2.1.2 Advancement in veterinary orthopedic technology
      • 3.2.1.3 Expansion of pet insurance coverage
      • 3.2.1.4 Increasing awareness among pet owners about orthopedic problems
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of orthopedic procedures and implants
      • 3.2.2.2 Limited availability of skilled veterinary orthopedic surgeons
    • 3.2.3 Market opportunities
      • 3.2.3.1 Increasing collaboration and partnership between implant manufacturers and veterinary hospitals
      • 3.2.3.2 Rapid urbanization and income growth in emerging markets
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Merger and acquisition
    • 4.6.2 Partnership and collaboration
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Implants
    • 5.2.1 Plates
      • 5.2.1.1 TPLO plates
      • 5.2.1.2 TTA plates
      • 5.2.1.3 Trauma plates
      • 5.2.1.4 Specialty plates
      • 5.2.1.5 Other plates
    • 5.2.2 Joint implants
    • 5.2.3 Bone screws and anchors
    • 5.2.4 Pins and Wires
    • 5.2.5 Other implants
  • 5.3 Instruments

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Small and medium animals
    • 6.2.1 Dogs
    • 6.2.2 Cats
    • 6.2.3 Other small and medium animals
  • 6.3 Large animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Tibial Plateau Leveling Osteotomy (TPLO)
  • 7.3 Tibial Tuberosity Advancement (TTA)
  • 7.4 Joint replacement
    • 7.4.1 Hip replacement
    • 7.4.2 Knee replacement
    • 7.4.3 Elbow replacement
    • 7.4.4 Ankle replacement
  • 7.5 Trauma
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Veterinary hospitals and clinics
  • 8.3 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 AmerisourceBergen Corporation (Cencora, Inc.)
  • 10.2 Arthrex Vet Systems
  • 10.3 B. Braun
  • 10.4 BlueSAO
  • 10.5 DePuy Synthes (Johnson & Johnson)
  • 10.6 Fusion Implants
  • 10.7 GerVetUSA
  • 10.8 GPC Medical Ltd.
  • 10.9 Integra LifeSciences
  • 10.10 Movora (Vimian Group)
  • 10.11 Narang Medical Limited
  • 10.12 Ortho Max
  • 10.13 Orthomed
  • 10.14 Rita Leibinger
  • 10.15 Veterinary Instrumentation
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦